Cite

HARVARD Citation

    Weppler, A. et al. (2020). Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record